מקדם חוב לטווח ארוך להון Novo Integrated Sciences Corp (NVOS)

Novo Integrated Sciences (NVOS) management aims to merge scientific research with healthcare delivery to extend human life. The business relies on a network of decentralized centers and IT services, adhering to strict HIPAA standards and state licensing. This price trend chart on GURU.Markets shows a value of 0.00, while the company remains marginalized, utilizing questionable financing methods without a real market share.

The ratio is calculated as the proportion of liabilities with a maturity exceeding one year to equity. This metric determines the issuer's financial autonomy and the degree of dependence on long-term debt capital. For the non-cyclical healthcare business of Novo Integrated Sciences (NVOS), low leverage guarantees stability during macroeconomic shocks. Analyzing the long-term debt-to-equity ratio allows for an assessment of the balance between security and investment efficiency.